Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Publications
  • In the News

Macrophage Therapeutics Produces First Two Immunoconstructs

Sep 25, 2015

Navidea Biopharmaceuticals to Present at the Ladenburg Thalmann 2015 Healthcare Conference

Sep 17, 2015

Navidea Awarded $1.8M Fast Track NIH SBIR Grant for Evaluation of a Manocept™ Agent in Kaposi’s Sarcoma

Sep 3, 2015

Navidea Biopharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

Sep 2, 2015

Navidea Biopharmaceuticals Announces Dual Listing on Tel Aviv Stock Exchange

Sep 2, 2015

Navidea Biopharmaceuticals to Present at Sidoti Emerging Growth Conference

Aug 25, 2015

Navidea Biopharmaceuticals to Register Shares for Dual Listing on Tel-Aviv Stock Exchange

Aug 24, 2015

Navidea Reports Publication of Lymphoseek® Comparative Results in Injection Site Pain Study in Breast Cancer

Aug 20, 2015

Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance

Jul 30, 2015

Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept™ in Rheumatoid Arthritis

Jul 29, 2015
    • 1...
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • ...45
    © 2025 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap